BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Meer S, de Man RA, van den Berg AP, Houwen RH, Linn FH, van Oijen MG, Siersema PD, van Erpecum KJ. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up. J Gastroenterol Hepatol. 2015;30:535-539. [PMID: 25160780 DOI: 10.1111/jgh.12716] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Brandi G, Rizzo A, Deserti M, Relli V, Indio V, Bin S, Pariali M, Palloni A, De Lorenzo S, Tovoli F, Tavolari S. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster. BMC Med Genet 2020;21:225. [PMID: 33208122 DOI: 10.1186/s12881-020-01165-0] [Reference Citation Analysis]
2 Richard JN, Graham JE, Center SA, Garner MM, Reavill DR. Hepatic copper accumulates in ferrets with and without hepatobiliary disease. ajvr 2022. [DOI: 10.2460/ajvr.21.08.0131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mordaunt CE, Kieffer DA, Shibata NM, Członkowska A, Litwin T, Weiss KH, Zhu Y, Bowlus CL, Sarkar S, Cooper S, Wan YY, Ali MR, LaSalle JM, Medici V. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Epigenetics Chromatin 2019;12:10. [PMID: 30709419 DOI: 10.1186/s13072-019-0255-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
4 Gunjan D, Shalimar, Nadda N, Kedia S, Nayak B, Paul SB, Gamanagatti SR, Acharya SK. Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease. J Clin Exp Hepatol 2017;7:152-4. [PMID: 28663680 DOI: 10.1016/j.jceh.2016.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yuan XZ, Yang RM, Wang XP. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy. Curr Neuropharmacol 2021;19:465-85. [PMID: 32351182 DOI: 10.2174/1570159X18666200429233517] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhong HJ, Zhuang YP, Zhang YT, Xu SP, Hong MF, He XX. Distinguishing between the complications of Wilson disease-related cirrhosis and HBV-related cirrhosis. Curr Med Res Opin 2021;:1-7. [PMID: 34665066 DOI: 10.1080/03007995.2021.1993160] [Reference Citation Analysis]
7 Sergi CM. Carcinoma of the Liver in Children and Adolescents. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 1-38. [DOI: 10.36255/exonpublications.livercancer.2021.ch1] [Reference Citation Analysis]
8 Ahmad A, Torrazza-Perez E, Schilsky ML. Liver transplantation for Wilson disease. Handb Clin Neurol 2017;142:193-204. [PMID: 28433103 DOI: 10.1016/B978-0-444-63625-6.00016-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Kathawala M, Hirschfield GM. Insights into the management of Wilson's disease. Therap Adv Gastroenterol. 2017;10:889-905. [PMID: 29147139 DOI: 10.1177/1756283x17731520] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Schroeder SM, Matsukuma KE, Medici V. Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features. Ann Transl Med 2021;9:1394. [PMID: 34733946 DOI: 10.21037/atm-21-2264] [Reference Citation Analysis]
11 Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol 2018; 24(35): 3980-3999 [PMID: 30254403 DOI: 10.3748/wjg.v24.i35.3980] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 45] [Article Influence: 16.5] [Reference Citation Analysis]
12 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 927] [Cited by in F6Publishing: 880] [Article Influence: 185.4] [Reference Citation Analysis]
13 Vierling JM, Sussman NL. Wilson Disease in Adults. Clinical and Translational Perspectives on WILSON DISEASE. Elsevier; 2019. pp. 165-77. [DOI: 10.1016/b978-0-12-810532-0.00016-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Boga S, Ala A, Schilsky ML. Hepatic features of Wilson disease. Handb Clin Neurol. 2017;142:91-99. [PMID: 28433114 DOI: 10.1016/b978-0-444-63625-6.00009-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
15 Aggarwal A, Bhatt M. Wilson disease. Current Opinion in Neurology 2020;33:534-42. [DOI: 10.1097/wco.0000000000000837] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lynch EN, Campani C, Innocenti T, Dragoni G, Forte P, Galli A. Practical insights into chronic management of hepatic Wilson’s disease. World J Clin Cases 2022; 10(14): 4334-4347 [DOI: 10.12998/wjcc.v10.i14.4334] [Reference Citation Analysis]
17 Tu T, Budzinska MA, Shackel NA, Jilbert AR. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma. Liver Int 2015;35:1786-800. [PMID: 25640596 DOI: 10.1111/liv.12773] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
18 Nilsson R, Liu N. Nuclear DNA damages generated by reactive oxygen molecules (ROS) under oxidative stress and their relevance to human cancers, including ionizing radiation-induced neoplasia part II: Relation between ROS-induced DNA damages and human cancer. Radiation Medicine and Protection 2020;1:196-204. [DOI: 10.1016/j.radmp.2020.11.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ismail MS, Hassan M, Martinez-Camacho A, May SB, Goss JA, Kanwal F, Jalal PK. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int 2020;33:925-35. [PMID: 32314442 DOI: 10.1111/tri.13622] [Reference Citation Analysis]
20 Tarocchi M, Galli A. Oxidative Stress as a Mechanism for Hepatocellular Carcinoma. Liver Pathophysiology. Elsevier; 2017. pp. 279-87. [DOI: 10.1016/b978-0-12-804274-8.00021-7] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020;38:417-432. [PMID: 32279718 DOI: 10.1016/j.ncl.2020.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
22 Dohan A, Vargas O, Dautry R, Guerrache Y, Woimant F, Hamzi L, Boudiaf M, Poujois A, Faraoun SA, Soyer P. MR imaging features of focal liver lesions in Wilson disease. Abdom Radiol (NY) 2016;41:1811-24. [PMID: 27116011 DOI: 10.1007/s00261-016-0744-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Zhong HJ, Xiao P, Lin D, Zhou HM, He XX. Cirrhosis in Wilson Disease is characterized by Impaired Hepatic Synthesis, Leukopenia and Thrombocytopenia. Int J Med Sci 2020;17:1345-50. [PMID: 32624691 DOI: 10.7150/ijms.44338] [Reference Citation Analysis]
24 Mohr I, Weiss KH. Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. Clin Biochem Rev 2019;40:59-77. [PMID: 31205375 DOI: 10.33176/AACB-18-00014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
25 Garrido I, Marques M, Liberal R, Cardoso H, Lopes S, Macedo G. Wilson disease in Northern Portugal: a long-term follow-up study. Orphanet J Rare Dis 2022;17:82. [PMID: 35197085 DOI: 10.1186/s13023-022-02245-5] [Reference Citation Analysis]
26 Choe EJ, Choi JW, Kang M, Lee YK, Jeon HH, Park BK, Won SY, Cho YS, Seo JH, Lee CK, Chung JB. A population-based epidemiology of Wilson's disease in South Korea between 2010 and 2016. Sci Rep 2020;10:14041. [PMID: 32820224 DOI: 10.1038/s41598-020-70976-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kasztelan-Szczerbinska B, Cichoz-Lach H. Wilson's Disease: An Update on the Diagnostic Workup and Management. J Clin Med 2021;10:5097. [PMID: 34768617 DOI: 10.3390/jcm10215097] [Reference Citation Analysis]
28 Harro CC, Smedley RC, Buchweitz JP, Langlois DK. Hepatic copper and other trace mineral concentrations in dogs with hepatocellular carcinoma. J Vet Intern Med 2019;33:2193-9. [PMID: 31493348 DOI: 10.1111/jvim.15619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kröner PT, Aby ES, Wijarnpreecha K, Palmer W. Wilson disease-related cirrhosis is associated with increased odds of hemolytic anemia. J Evid Based Med 2022;15:15-8. [PMID: 35416435 DOI: 10.1111/jebm.12463] [Reference Citation Analysis]